Placebo as SC Injection

DRUG2 trials

Sponsors

Eli Lilly and Company, Carmot Therapeutics, Inc.

Conditions

DiabetesType 2 Diabetes Mellitus

Phase 1

A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose

CompletedNCT04973111

Carmot Therapeutics, Inc.Diabetes

Start: 2021-07-16End: 2022-04-22Updated: 2025-03-28

Phase 3

A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus

CompletedNCT01644500

Eli Lilly and CompanyType 2 Diabetes Mellitus

Start: 2012-07-31End: 2014-08-31Updated: 2019-09-18

Related Papers

Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies

Diabetes Therapy2020-08-284 citations

Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type 2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials

Diabetes Therapy2020-07-045 citations

2188-PUB: Efficacy and Safety in Chinese T2D Patients Discontinued from OAM to Once-Weekly Dulaglutide Monotherapy

Diabetes2020-06-01

Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis

Diabetes Therapy2020-04-109 citations

Efficacy and Safety of Dulaglutide Monotherapy Compared to Glimepiride in Oral Antihyperglycemic Medication-Naïve Chinese patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN1.

2020-03-263 citations

Achieving the composite end‐point of glycated hemoglobin <7.0% without weight gain or hypoglycemia with once‐weekly dulaglutide in Chinese patients with type 2 diabetes: A post‐hoc analysis

Journal of Diabetes Investigation2019-11-233 citations

2313-PUB: Efficacy by Baseline BMI with Once Weekly Dulaglutide in Chinese T2DM Patients

Diabetes2019-06-011 citations

A Randomized Study to Compare the Effects of Once-Weekly Dulaglutide Injection and Once-Daily Glimepiride on Glucose Fluctuation of Type 2 Diabetes Mellitus Patients: A 26-Week Follow-Up

Journal of Diabetes Research2019-04-3018 citations